Oppenheimer analyst Justin Kim assumes coverage on Aduro Biotech (NASDAQ: ADRO) with a Perform rating.The analyst commented, "We are assuming ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE